Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements | |
Wu, Shafei; Wang, Jinghui; Zhou, Lijuan; Su, Dan; Liu, Yuanyuan; Liang, Xiaolong; Zhang, Shucai; Zeng, Xuan | |
2015 | |
卷号 | 6期号:4页码:413-420 |
关键词 | Fluorescent in situ hybridization lung adenocarcinoma ROS1 |
ISSN号 | 1759-7706 |
DOI | 10.1111/1759-7714.12191 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6662659 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wu, Shafei,Wang, Jinghui,Zhou, Lijuan,et al. Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements[J],2015,6(4):413-420. |
APA | Wu, Shafei.,Wang, Jinghui.,Zhou, Lijuan.,Su, Dan.,Liu, Yuanyuan.,...&Zeng, Xuan.(2015).Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements.,6(4),413-420. |
MLA | Wu, Shafei,et al."Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements".6.4(2015):413-420. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论